Cleveland Clinic Pulmonologist Takes Helm at Pulmonary Fibrosis Foundation
The Pulmonary Fibrosis Foundation announced Franck Rahaghi, MD, MHS, FCCP, as its incoming president, CEO, and chief medical officer, effective Sept 15.
Category: Pulmonary Fibrosis
Pulmonary Fibrosis
Latest
Pulmonary Fibrosis
Latest
UIC Scientists Receive $13 Million to Study Lung Inflammation Mechanisms
The researchers hope the projects will lead to new avenues for treatments to help patients with conditions like COPD, pulmonary fibrosis, and acute respiratory distress syndrome.
Pulmonary Fibrosis
Latest
Study: Nintedanib for Idiopathic Pulmonary Fibrosis
A study in the journal Respiration showed that patients with idiopathic pulmonary fibrosis who were treated with nintedanib saw more positive outcomes.
Black Patients Undiagnosed, Under-diagnosed Due to ‘Race Correction’ in PFT
The removal of race correction in PFT results led to an increase in the percentage of patients with any pulmonary defect from 59.5% to 81.7%, a significant difference of 20.8%.
Read More
Study: Pulmonary Hypertension in Patients With Pulmonary Fibrosis
A new literature review looks at the role of pulmonary hypertension in people with pulmonary fibrosis.
Read More
Studying Precision Medicine for Pulmonary Fibrosis
The PRECISIONS clinical trial will determine if N-Acetyl-cysteine (NAC) is an effective treatment in a subset of IPF patients who carry a particular genetic variant.
Read More
Phase 3 Study Underway for Inhaled Nitric Oxide Treatment of Interstitial Lung Disease
The first patient has been enrolled in Bellerophon’s Phase 3 study of pulsed inhaled nitric oxide to treat fibrotic interstitial lung disease.
Read More
Pulmonary Fibrosis Foundation Scholar receives NIH award
The Pulmonary Fibrosis Foundation reports that 2019 PFF Scholar, Dr. Jeremy Katzen has received a National Institutes of Health K08 award.
Read More
Lung Fibrosis Therapies Being Developed by Purdue
The first of the Purdue team’s novel targeted molecules is designed to slow fibrosis and extend life. The second IPF therapy suppresses fibrosis-inducing cytokine production.
Read More
ATS Research Program, 4DMedical Announce Grant Opportunities for Research in Asthma, COPD and IPF
The ATS Research Program announced three research grant opportunities with support from 4DMedical, a global medical technology company with a focus on lung health.
Read More
Pulmonary Fibrosis: New Recommendations for Genetic Testing
The PFF recommends patients with possible or likely genetic forms of pulmonary fibrosis be considered for genetic evaluation when possible to determine whether genetic testing is appropriate.
Read More
A Spotlight on the Pulmonary Fibrosis Foundation Care Center Network
The Pulmonology Advisor interviewed experts to learn about how the Pulmonary Fibrosis Foundation’s PFF Care Center Network can advance research.
Read More
Pulmonary Fibrosis Awareness Month Celebrates PF Heroes
September is Pulmonary Fibrosis Awareness Month. This year the Pulmonary Fibrosis Foundation is celebrating PF Heroes who are raising awareness of the disease.
Read More
Guidance for Using High-Resolution CT for Interstitial Lung Disease
The Pulmonary Fibrosis Fdn has issued a position statement that serves as a guide for conducting high-resolution computed tomography of the thorax for interstitial lung disease.
Read More
Yale, Baylor Create Atlas of Cellular Change in Lungs with Fibrosis
A research team from Yale and Baylor College of Medicine completed a single-cell analysis of lungs affected by idiopathic pulmonary fibrosis (IPF), revealing how cells change in response to the disease.
Read More